Found: 19
Select item for more details and to access through your institution.
Positive‐strand RNA viruses—a Keystone Symposia report.
- Published in:
- Annals of the New York Academy of Sciences, 2023, v. 1521, n. 1, p. 46, doi. 10.1111/nyas.14957
- By:
- Publication type:
- Article
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease.
- Published in:
- Nature Medicine, 2012, v. 18, n. 12, p. 1820, doi. 10.1038/nm.2972
- By:
- Publication type:
- Article
Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses.
- Published in:
- Journal of Infectious Diseases, 2014, v. 209, n. 7, p. 995, doi. 10.1093/infdis/jit609
- By:
- Publication type:
- Article
The coronavirus proofreading exoribonuclease mediates extensive viral recombination.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 1, p. 1, doi. 10.1371/journal.ppat.1009226
- By:
- Publication type:
- Article
ANDES: Statistical tools for the ANalyses of DEep Sequencing.
- Published in:
- BMC Research Notes, 2010, v. 3, p. 199, doi. 10.1186/1756-0500-3-199
- By:
- Publication type:
- Article
Human Rotaviruses of Multiple Genotypes Acquire Conserved VP4 Mutations during Serial Passage.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 6, p. 978, doi. 10.3390/v16060978
- By:
- Publication type:
- Article
Novel Poxvirus Infection in 2 Patients From the United States.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication Fidelity.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 12, p. 1, doi. 10.1371/journal.ppat.1003760
- By:
- Publication type:
- Article
Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 8, p. 1, doi. 10.1371/journal.ppat.1003565
- By:
- Publication type:
- Article
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 1, p. 1, doi. 10.1371/journal.ppat.1001258
- By:
- Publication type:
- Article
Infidelity of SARS-CoV Nsp14-Exonuclease Mutant Virus Replication Is Revealed by Complete Genome Sequencing.
- Published in:
- PLoS Pathogens, 2010, v. 6, n. 5, p. 1, doi. 10.1371/journal.ppat.1000896
- By:
- Publication type:
- Article
Cardiac Arrhythmias in an Adolescent Following Ingestion of an Over-the-counter Stimulant.
- Published in:
- Clinical Pediatrics, 1982, v. 21, n. 11, p. 700, doi. 10.1177/000992288202101112
- By:
- Publication type:
- Article
Seeking Membranes: Positive-Strand RNA Virus Replication Complexes.
- Published in:
- PLoS Biology, 2008, v. 6, n. 10, p. 2098, doi. 10.1371/journal.pbio.0060270
- By:
- Publication type:
- Article
MECHANISM AND RESISTANCE STUDIES OF SARS-CoV-2 MPRO INHIBITOR POMOTRELVIR (PBI-0451).
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 216
- By:
- Publication type:
- Article
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 656, p. 1, doi. 10.1126/scitranslmed.abo0718
- By:
- Publication type:
- Article
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-13940-6
- By:
- Publication type:
- Article
Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, n. 11, p. 1493, doi. 10.1086/652655
- By:
- Publication type:
- Article